{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:08:37Z","timestamp":1784815717346,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002349","name":"ASRT","doi-asserted-by":"publisher","award":["ASRT-4\/2016"],"award-info":[{"award-number":["ASRT-4\/2016"]}],"id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejps.2019.01.023","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T15:16:10Z","timestamp":1548429370000},"page":"124-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["New thiobarbituric acid scaffold-based small molecules: Synthesis, cytotoxicity, 2D-QSAR, pharmacophore modelling and in-silico ADME screening"],"prefix":"10.1016","volume":"130","author":[{"given":"Heba S.A.","family":"El-Zahabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomna M.H.","family":"Gado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel M.","family":"Farrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Elaasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen A.","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham R.","family":"AbdelRaouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem K.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.01.023_bb0005","first-page":"537","article-title":"Synthesis and antioxidant activity of some derivatives of 2-(2-oxo-4-phenyl-2h-chromen-7-yloxy)AcetoHydrazide","volume":"3","author":"Abd El-All","year":"2013","journal-title":"J. Atoms Mol."},{"key":"10.1016\/j.ejps.2019.01.023_bb0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/molecules18022084","article-title":"The reaction of ethyl 2-oxo-2H-chromene-3-carboxylate with hydrazine hydrate","volume":"18","author":"Abdel-Aziz","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2019.01.023_bb0015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2174\/1389557518666180903153254","article-title":"New 1-phthalazinone scaffold based compounds: design, synthesis, cytotoxicity and protein kinase inhibition activity","volume":"18","author":"Abo-Elmagd","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4236\/ijoc.2011.14030","article-title":"Dimethylformamide dimethyl acetal (DMFDMA) in heterocyclic synthesis: synthesis of polysubstituted pyridines, pyrimidines, pyridazine and their fused derivatives","volume":"1","author":"Abu-Shanab","year":"2011","journal-title":"Int. J. Org. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0025","series-title":"Chemistry Select","first-page":"7060","article-title":"Design, synthesis and anticancer evaluation of oxa\/thiadiazolylhydrazones of barbituric and thiobarbituric acid: a collective in vitro and in silico approach","volume":"3","author":"Bhatt","year":"2018"},{"key":"10.1016\/j.ejps.2019.01.023_bb0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2174\/138161213804581954","article-title":"Rejuvenating sirtuins: the rise of a new family of cancer drug targets","volume":"19","author":"Bruzzone","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2019.01.023_bb0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","article-title":"Phantom PAINS: Problems with the utility of alerts for pan-assay INterference CompoundS","volume":"57","author":"Capuzzi","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2019.01.023_bb0040","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.bbapap.2009.11.010","article-title":"Sirtuins inhibitors: the approach to affinity and selectivity: a review","volume":"1804","author":"Cen","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2019.01.023_bb0045","first-page":"1151","article-title":"Clinical Phase I pharmacological study of Merbarone","volume":"50","author":"Dimaggio","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.01.023_bb0050","first-page":"293","article-title":"Synthesis and antitumor activity of some new N-substituted-sulfonyl, 1,2,4-triazole, N-substituted-benzylidene and pyrrole derivatives attached to 4-(benzo[d]thiazol-2-yl)benzohydrazide","volume":"3","author":"El-Hamouly","year":"2011","journal-title":"Der pharma chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0055","first-page":"182","article-title":"Synthesis and cytotoxic evaluation of some novel 6-(Benzofuran-2-yl)-4-(4-Fluorophenyl)pyridines","volume":"4","author":"El-Zahar","year":"2009","journal-title":"World J. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejmech.2017.11.070","article-title":"Trisubstituted barbiturates and thiobarbiturates: synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative agents","volume":"143","author":"Figueiredo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0065","doi-asserted-by":"crossref","first-page":"17643","DOI":"10.1074\/jbc.273.28.17643","article-title":"Merbarone inhibits the catalytic activity of human topoisomerase II\u03b1 by blocking DNA cleavage","volume":"273","author":"Fortune","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0070","series-title":"The WEKA Workbench. Online Appendix for \"Data Mining: Practical Machine Learning Tools and Techniques\"","author":"Frank","year":"2016"},{"key":"10.1016\/j.ejps.2019.01.023_bb0075","series-title":"ACM SIGKDD Explorations Newsletter","first-page":"10","article-title":"The WEKA data mining software: an update","volume":"11","author":"Hall","year":"2009"},{"key":"10.1016\/j.ejps.2019.01.023_bb0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ardp.200700266","article-title":"Design and synthesis of novel Benzopyran-2-one derivatives of expected antimicrobial activity through DNA gyrase-B inhibition","volume":"341","author":"Hassan","year":"2008","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejps.2019.01.023_bb0090","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2147\/DDDT.S68016","article-title":"Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues","volume":"8","author":"Ismail","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2019.01.023_bb0095","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1039\/c2ob26081f","article-title":"Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimization","volume":"10","author":"Kong","year":"2012","journal-title":"Org. Biomol. Chem."},{"issue":"13","key":"10.1016\/j.ejps.2019.01.023_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3998\/ark.5550190.0009.d19","article-title":"Substituted benzoic acid benzylidene\/furan-2-yl-methylidene hydrazides: synthesis, antimicrobial evaluation and QSAR analysis","author":"Kumar","year":"2008","journal-title":"ARKIVOC"},{"key":"10.1016\/j.ejps.2019.01.023_bb0105","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ejmech.2010.03.002","article-title":"Benzylidene\/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation","volume":"45","author":"Kumar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","article-title":"Catalytic topoisomerase II inhibitors in cancer therapy","volume":"99","author":"Larsen","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2019.01.023_bb0115","first-page":"510","article-title":"Evaluation of inhibitory effects of thiobarbituric acid derivatives targeting HCV NS5B polymerase","volume":"20","author":"Lee","year":"2010","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejps.2019.01.023_bb0120","series-title":"2016.08; Chemical Computing Group Inc., 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7","author":"Molecular Operating Environment (MOE)","year":"2016"},{"key":"10.1016\/j.ejps.2019.01.023_bb0125","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bmcl.2012.12.053","article-title":"5-((1-Aroyl-1H-indol-3-yl)methylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-diones as potential anticancer agents with anti-inflammatory properties","volume":"23","author":"Penthala","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.01.023_bb0130","series-title":"e-EROS","article-title":"N,N-Dimethylformamide diethyl Acetal","author":"Pindur","year":"2001"},{"key":"10.1016\/j.ejps.2019.01.023_bb0135","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1535-7163.MCT-07-0147","article-title":"Gambogic acid inhibits the catalytic activity of human topoisomerase II\u03b1 by binding to its ATPase domain","volume":"6","author":"Qin","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2019.01.023_bb0140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2014.06.007","article-title":"Design, synthesis and structure\u2013activity relationship of novel semi-synthetic flavonoids as antiproliferative agents","volume":"82","author":"Ragab","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0145","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.bmcl.2009.04.132","article-title":"Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors","volume":"19","author":"Rajamaki","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.01.023_bb0150","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ejmech.2017.11.006","article-title":"Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells","volume":"143","author":"Ramisetti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0155","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/S0968-0896(03)00158-5","article-title":"Synthesis and antiproliferative activity of basic thioanalogues of merbarone","volume":"11","author":"Ranise","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2019.01.023_bb0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2009.01.040","article-title":"Histone deacetylase inhibitors that target tubulin","volume":"280","author":"Schemies","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2019.01.023_bb0165","volume":"7","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2019.01.023_bb0170","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/10091161","article-title":"Synthesis of oxadiazoles, thiadiazoles and triazoles derived from benzo[b]thiophene","volume":"10","author":"Sharba","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2019.01.023_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11693-011-9069-4","article-title":"Design of a novel nucleoside analog as potent inhibitor of the NAD dependent deacetylase, SIRT2","volume":"4","author":"Sivaraman","year":"2011","journal-title":"Syst. Synth. Biol."},{"key":"10.1016\/j.ejps.2019.01.023_bb0180","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2019.01.023_bb0185","first-page":"260","article-title":"Synthesis and evaluation of new phenylaminothiadiazolo-oxadiazolo-1,3benzoxazoles for their antibacterial activity","volume":"1","author":"Srikanth","year":"2010","journal-title":"Int J Pharm. Bio. Sci"},{"key":"10.1016\/j.ejps.2019.01.023_bb0190","unstructured":"D.C. Young, T.R. Bailey, Methods for treating or preventing viral infections and associated diseases, US Patent 9920402, 2001."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T05:42:51Z","timestamp":1606196571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S0928098719300272"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.01.023","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New thiobarbituric acid scaffold-based small molecules: Synthesis, cytotoxicity, 2D-QSAR, pharmacophore modelling and in-silico ADME screening","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}